BluGlass Receives First Trial RPCVD Epitaxy Order and Appoints International Agent for Custom MOCVD

Key Points:

  • BluGlass has received its first order for its unique low temperature RPCVD process for a trial on specialty engineered silicon wafers

  • BluGlass has appointed an expert custom epitaxy (foundry) agent xVI Technologies for its MOCVD custom epitaxy service

  • Results being produced by BLG-300 are now on par with the results of the BLG-180, the 5th generation system

Click here to read the announcement

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

LATEST NEWS

INVESTOR INFO

CONTACT US

ASX  :   BLG

BluGlass is an Australian public company listed on the Australian Stock Exchange to bring to market a breakthrough in the semiconductor technology industry.

INVESTOR MAIL

74 Asquith Street

Silverwater, NSW, 2128
Australia

P: +61 2 9334 2300

FOLLOW US
  • LinkedIn Social Icon
  • Twitter Social Icon